- Home
- CATO vs YI Comparison
CATO vs YI Comparison
Compare CATO & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- YI
- Stock Information
- Founded
- CATO 1946
- YI 2010
- Country
- CATO United States
- YI China
- Employees
- CATO N/A
- YI N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- CATO Consumer Discretionary
- YI Consumer Staples
- Exchange
- CATO Nasdaq
- YI Nasdaq
- Market Cap
- CATO 77.6M
- YI 71.1M
- IPO Year
- CATO N/A
- YI N/A
- Fundamental
- Price
- CATO $3.38
- YI $6.38
- Analyst Decision
- CATO
- YI
- Analyst Count
- CATO 0
- YI 0
- Target Price
- CATO N/A
- YI N/A
- AVG Volume (30 Days)
- CATO 70.3K
- YI 57.6K
- Earning Date
- CATO 03-20-2025
- YI 03-20-2025
- Dividend Yield
- CATO 15.22%
- YI N/A
- EPS Growth
- CATO N/A
- YI N/A
- EPS
- CATO N/A
- YI N/A
- Revenue
- CATO $666,779,000.00
- YI $2,090,255,896.00
- Revenue This Year
- CATO N/A
- YI $61.85
- Revenue Next Year
- CATO N/A
- YI N/A
- P/E Ratio
- CATO N/A
- YI N/A
- Revenue Growth
- CATO N/A
- YI N/A
- 52 Week Low
- CATO $3.02
- YI $0.41
- 52 Week High
- CATO $7.05
- YI $6.95
- Technical
- Relative Strength Index (RSI)
- CATO 38.50
- YI 94.38
- Support Level
- CATO $3.46
- YI $5.55
- Resistance Level
- CATO $3.93
- YI $6.95
- Average True Range (ATR)
- CATO 0.18
- YI 0.35
- MACD
- CATO -0.01
- YI 0.52
- Stochastic Oscillator
- CATO 28.00
- YI 93.11
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.